Venlon Enterprises Limited, headquartered in **Mysuru**, is currently navigating a high-stakes strategic pivot. Historically a diversified manufacturer, the company has systematically exited its industrial production lines to transition toward a **trading-focused business model**. This shift is necessitated by severe financial distress, including the total erosion of net worth and the cessation of all primary manufacturing activities as of **late 2025**. --- ### **Strategic Pivot: From Manufacturing to Trading** The company has undergone a total transformation of its operational core, moving away from capital-intensive manufacturing toward a model centered on the purchase and sale of chemical products. * **Trading Operations:** The current business strategy focuses on the trading of **Formaldehyde** and **Paraformaldehyde**. These activities are highly dependent on the "availability of funds" and are conducted through a purchase-and-sale model rather than in-house production. * **Cessation of Legacy Segments:** The company has systematically shuttered its historical divisions due to adverse market conditions: * **Polyester Film:** Discontinued in **September 2018**. * **Formaldehyde/Para-formaldehyde Manufacturing:** Production stopped in **FY 2021-22**. * **Wind-mill Operations (Power):** Operations ceased in **FY 2022-23**; assets were subsequently marked for disposal. * **Asset Utilization & Leasing:** Previously, the company attempted to generate revenue by leasing its **Formaldehyde** and **Paraformaldehyde** plants to **Dechem Resins Limited** (a related entity). However, the lessee permanently closed operations on **December 27, 2025**, leading to the termination of lease agreements and rental income effective **January 1, 2026**. --- ### **Financial Restructuring and Solvency Profile** Venlon Enterprises is currently operating under significant financial duress, with its **Going Concern** status maintained primarily through aggressive debt restructuring and the support of major shareholders. **Key Solvency Metrics:** * **Net Worth:** Reported as **fully eroded** (negative **₹7,859.72 Lacs** as of March 2023; remains negative through **February 2026**). * **Liquidity:** Current liabilities significantly exceed current assets. As of **September 30, 2025**, the company faced a critical liquidity crisis. * **Annual Performance:** The company recorded a loss of **₹2,454.23 Lacs** in FY 2022-23, largely driven by non-cash depreciation charges. **Debt Realignment Table:** | Instrument | Value | Status/Action | | :--- | :--- | :--- | | **External Commercial Borrowing (ECB)** | **USD 13.85 Million** (~**₹50 Crores**) | Reclassified as **Other Equity** (as of March 31, 2025) | | **Lender Identity** | **29% Shareholder** | Non-recourse, interest-free arrangement | | **Currency Risk Mitigation** | **USD to INR Swap** | MOU executed to convert debt to local currency | | **Repayment Moratorium** | **Until April 2030** | New schedule starts after a 5-year holiday | | **Total External Debt** | **₹9,964.41 Lacs** | Subject to ongoing deferment negotiations | --- ### **Asset Liquidation and Liability Management** To address its mounting obligations, management has initiated a program of asset monetization and liability offsets: * **Land for Debt:** Certain related parties have agreed to adjust outstanding loans against the **purchase of company land**. * **Asset Disposal:** Windmill assets and film segment machinery (written down to **5% scrap value**) are classified as **assets held for sale**. * **Inventory Provisions:** A **100% provision** has been made for non-moving inventory consisting of loose spares and consumables. * **Impairment Testing:** Following the cessation of manufacturing in **December 2025**, management is evaluating the recoverable amount of the main factory facility, including a potential full sale of the site. --- ### **Maturity Profile of Financial Liabilities** The following table illustrates the company's immediate and long-term financial obligations as of the **March 2025** reporting cycle: | Particulars (₹ in Lacs) | < 1 Year | 1-5 Years | > 5 Years | Total | | :--- | :--- | :--- | :--- | :--- | | **Borrowings (2025)** | **2,203.63** | **-** | **-** | **2,203.63** | | **Trade Payables (2025)** | **214.36** | **-** | **-** | **214.36** | | *Borrowings (2024)* | *1,831.92* | *-* | *10,110.16* | *11,942.08* | *Note: The sharp decrease in long-term borrowings between 2024 and 2025 reflects the reclassification of the ECB loan into "Other Equity."* --- ### **Governance and Executive Leadership** The company is led by members of the Datwani family, who have recently committed to long-term tenures to oversee the transition. * **Shri. Chand D. Datwani (Chairman & Managing Director):** Re-appointed for a 3-year term (effective **March 2026 – March 2029**) with a salary of **₹5,00,000 per month**. Notably, he drew no remuneration during his previous tenure. * **Smt. Saroj C. Datwani (Whole-time Director & CFO):** Re-appointed for a 5-year term (effective **March 2026 – March 2031**). She has voluntarily **waived her remuneration** to support the company's cash flow. * **Independent Oversight:** The board includes **Mr. Devaraja Murthy N K** (term through 2030) and **Ms. Madhura Haldodderi Govindarao** (appointed May 2025). --- ### **Critical Risk Factors for Investors** 1. **Operational Viability:** With the permanent closure of manufacturing and the loss of rental income in **January 2026**, the company is entirely dependent on the success of its nascent trading business. 2. **Regulatory Approvals:** The reclassification of **₹50 Crores** in debt to equity and the **USD-to-INR currency swap** are subject to final approval from the **RBI** and other statutory authorities. 3. **Litigation:** The company is defending pending court cases from suppliers and employees totaling approximately **₹32 Lakhs**. 4. **Going Concern Uncertainty:** Statutory auditors continue to issue an **"Emphasis of Matter"** regarding the company's ability to meet liabilities. Survival is contingent upon the continued discretionary support of the 29% shareholder and successful asset liquidations. 5. **Market Exposure:** The entity remains vulnerable to **Credit Risk** from trading counterparties and **Liquidity Risk** due to the lack of a stable cash-generating core.